Incidence of De Novo Post-Transplant Malignancies in Thai Adult Kidney Transplant Recipients: A Single-Center, Population-Controlled, Retrospective Cohort Study at the Highest Volume Kidney Transplant Center in Thailand.

IF 2.7 3区 医学 Q1 SURGERY
Transplant International Pub Date : 2024-02-26 eCollection Date: 2024-01-01 DOI:10.3389/ti.2024.11614
Praopilad Srisuwarn, Napun Sutharattanapong, Sinee Disthabanchong, Surasak Kantachuvesiri, Chagriya Kitiyakara, Bunyong Phakdeekitcharoen, Atiporn Ingsathit, Vasant Sumethkul
{"title":"Incidence of <i>De Novo</i> Post-Transplant Malignancies in Thai Adult Kidney Transplant Recipients: A Single-Center, Population-Controlled, Retrospective Cohort Study at the Highest Volume Kidney Transplant Center in Thailand.","authors":"Praopilad Srisuwarn, Napun Sutharattanapong, Sinee Disthabanchong, Surasak Kantachuvesiri, Chagriya Kitiyakara, Bunyong Phakdeekitcharoen, Atiporn Ingsathit, Vasant Sumethkul","doi":"10.3389/ti.2024.11614","DOIUrl":null,"url":null,"abstract":"<p><p>Kidney transplant recipients (KTRs) are at increased risk of developing <i>de novo</i> post-transplant malignancies (PTMs), with regional differences in types with excess risk compared to the general population. A single-center, population-controlled, retrospective cohort study was conducted at a tertiary care center in Thailand among all adults who underwent their first kidney transplant from 1986 to 2018. Standardized incidence ratios (SIRs) of malignancy by age, sex, and place of residence were obtained using data from the National Cancer Registry of Thailand as population control. There were 2,024 KTRs [mean age, 42.4 years (SD 11.4); female patients, 38.6%] during 16,495 person-years at risk. Of these, 125 patients (6.2%) developed 133 <i>de novo</i> PTMs. The SIR for all PTMs was 3.85 (95% CI 3.22, 4.56), and for pooled solid and hematologic PTMs, it was 3.32 (95% CI 2.73, 3.99). Urothelial malignancies had the largest excess risk, especially in women [female SIR 114.7 (95% CI 66.8, 183.6); male SIR 17.5 (95% CI 8.72, 31.2)]. The next two most common cancers were non-Hodgkin's lymphoma and skin cancer [SIR 20.3 (95% CI 13.6, 29.1) and 24.7 (95% CI 15.3-37.8), respectively]. Future studies are needed to identify the risk factors and assess the need for systematic screening among PTMs with excess risk in KTRs.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"37 ","pages":"11614"},"PeriodicalIF":2.7000,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10926888/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplant International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/ti.2024.11614","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Kidney transplant recipients (KTRs) are at increased risk of developing de novo post-transplant malignancies (PTMs), with regional differences in types with excess risk compared to the general population. A single-center, population-controlled, retrospective cohort study was conducted at a tertiary care center in Thailand among all adults who underwent their first kidney transplant from 1986 to 2018. Standardized incidence ratios (SIRs) of malignancy by age, sex, and place of residence were obtained using data from the National Cancer Registry of Thailand as population control. There were 2,024 KTRs [mean age, 42.4 years (SD 11.4); female patients, 38.6%] during 16,495 person-years at risk. Of these, 125 patients (6.2%) developed 133 de novo PTMs. The SIR for all PTMs was 3.85 (95% CI 3.22, 4.56), and for pooled solid and hematologic PTMs, it was 3.32 (95% CI 2.73, 3.99). Urothelial malignancies had the largest excess risk, especially in women [female SIR 114.7 (95% CI 66.8, 183.6); male SIR 17.5 (95% CI 8.72, 31.2)]. The next two most common cancers were non-Hodgkin's lymphoma and skin cancer [SIR 20.3 (95% CI 13.6, 29.1) and 24.7 (95% CI 15.3-37.8), respectively]. Future studies are needed to identify the risk factors and assess the need for systematic screening among PTMs with excess risk in KTRs.

泰国成人肾移植受者移植后新发恶性肿瘤的发生率:泰国移植量最大的肾移植中心的单中心、人群控制、回顾性队列研究。
肾移植受者(KTRs)罹患新发移植后恶性肿瘤(PTMs)的风险增加,与普通人群相比,超风险类型存在地区差异。泰国一家三级医疗中心对1986年至2018年期间接受首次肾移植的所有成人进行了一项单中心、人群对照、回顾性队列研究。以泰国国家癌症登记处的数据作为人群对照,获得了按年龄、性别和居住地划分的恶性肿瘤标准化发病率(SIR)。在 16495 人年的风险期内,共有 2024 名 KTR [平均年龄 42.4 岁(标准差 11.4);女性患者占 38.6%]。其中,125 名患者(6.2%)出现了 133 个新的 PTM。所有 PTM 的 SIR 为 3.85 (95% CI 3.22, 4.56),合并实体和血液 PTM 的 SIR 为 3.32 (95% CI 2.73, 3.99)。泌尿系统恶性肿瘤的超额风险最大,尤其是女性[女性 SIR 为 114.7 (95% CI 66.8, 183.6);男性 SIR 为 17.5 (95% CI 8.72, 31.2)]。其次是非霍奇金淋巴瘤和皮肤癌[SIR 分别为 20.3 (95% CI 13.6, 29.1) 和 24.7 (95% CI 15.3-37.8)]。未来的研究需要确定风险因素,并评估是否需要对 KTR 中风险过高的 PTM 进行系统筛查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Transplant International
Transplant International 医学-外科
CiteScore
4.70
自引率
6.50%
发文量
211
审稿时长
3-8 weeks
期刊介绍: The aim of the journal is to serve as a forum for the exchange of scientific information in the form of original and high quality papers in the field of transplantation. Clinical and experimental studies, as well as editorials, letters to the editors, and, occasionally, reviews on the biology, physiology, and immunology of transplantation of tissues and organs, are published. Publishing time for the latter is approximately six months, provided major revisions are not needed. The journal is published in yearly volumes, each volume containing twelve issues. Papers submitted to the journal are subject to peer review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信